FZP regulates HCC‐related signaling pathways, including the PIK3‐Akt signaling pathway, PD‐L1 expression, and PD‐1 checkpoint pathway in cancer, to treat HCC. This evidence concerns the gene PIK3CG and hepatocellular carcinoma.